Form 4: Cardio Diagnostics Holdings Director Acquires Stock Options
SEC Form 4 Filing
James Intrater, a director of Cardio Diagnostics Holdings, acquired 18,939 stock options at an exercise price of $0.33 on March 31, 2025.
Summary
- On March 31, 2025, James Intrater, a director of Cardio Diagnostics Holdings, Inc., acquired 18,939 stock options.
- The exercise price for these options is $0.33.
- The options are exercisable immediately and expire on March 31, 2035.
- Following the transaction, Intrater beneficially owns 49,744 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing (Form 4) detailing a director's acquisition of stock options. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the holdings and transactions of company directors. It's a standard practice for publicly traded companies and their insiders.
Stakeholder Impact
- The acquisition of stock options by a director could be viewed positively by shareholders as it aligns the director's interests with the company's performance.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of earliest transaction: James Intrater acquired 18,939 stock options at $0.33. |
| 03/31/2025 | Date the stock options are exercisable. |
| 03/31/2035 | Expiration date of the stock options. |
| 04/01/2025 | Date of signature on the Form 4 filing. |
Keywords
stock options, Form 4, director, CDIO, Cardio Diagnostics Holdings, beneficial ownership, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.